GROWTH INHIBITORY ACTIVITY OF ELSHOLTZIA CILIATA (THUNB.) HYLAND EXTRACT ON LIVER CANCER CELLS HEPG2

Lê Thị Thanh Hương; Mai Văn Linh; Phạm Ngô Minh Châu; Cao Quốc Khánh; Phạm Văn Khang; Nguyễn Phú Hùng

doi:10.34238/tnu-jst.6963

GROWTH INHIBITORY ACTIVITY OF ELSHOLTZIA CILIATA (THUNB.) HYLAND EXTRACT ON LIVER CANCER CELLS HEPG2

About this article

Received: 22/11/22 Revised: 26/12/22 Published: 30/01/23

Authors

1. Le Thi Thanh Huong , TNU - University of Sciences
2. Mai Van Linh, TNU - University of Sciences
3. Pham Ngo Minh Chau, Thai Nguyen Specialized High School
4. Cao Quoc Khanh, Thai Nguyen Specialized High School
5. Pham Van Khang, TNU - University of Education
6. Nguyen Phu Hung, TNU - University of Sciences

Abstract

Liver cancer is the leading cancer causing death in the world. Studies on the anti-cancer potential of many other herbal species are of current interest. Elsholtzia ciliata (Thunb.) Hyland belongs to the genus Elsholtzia and is commonly used as a spice. It is also used as a remedy for colds and flu. However, its ability to inhibit liver cancer cells has not been studied. In this study, the methods of culture, cytotoxicity analysis, cell cycle and apoptosis are applied to evaluate the anti-cancer ability of Elsholtzia ciliata extract. The results showed that the leaf extract of Elsholtzia ciliata changed cell morphology at concentrations from 100 - 200 µg/mL compared to control. The extract effectively inhibited the proliferation of HepG2, the percentage of viable cells reduced to 41 ± 10.5% (at concentration of 100 µg/mL) and 20.4 ± 7.7% (at concentration of 200 µg/mL) compared to the control (P < 0.05). The extract stopped the cell cycle at G0/G1 phase (62.1 ± 3.5% vs 51.3 ± 4.2%, P < 0.05) and induced cellular apoptosis (P < 0.05). This study shows that Elsholtzia ciliata is a potential herb against liver cancer cells.

Keywords

Elsholtzia ciliata; Live cancer; Cell cycle; Apoptosis; Anti-cancer

Full Text:

PDF (Tiếng Việt)

References

[1] F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A. Jemal, "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries," CA: a cancer journal for clinicians, vol. 68, pp. 394-424, 2018.

[2] T. Akinyemiju, S. Abera, M. Ahmed, N. Alam, M. A. Alemayohu, C. Allen et al., "The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015," JAMA oncology, vol. 3, pp. 1683-1691, 2017.

[3] J. Bruix and M. Sherman, "Management of hepatocellular carcinoma: an update," Hepatology (Baltimore, Md.), vol. 53, p. 1020, 2011.

[4] M. Dickson and G. K. Schwartz, "Development of cell-cycle inhibitors for cancer therapy," Current oncology, vol. 16, pp. 36-43, 2009.

[5] S. Elmore, "Apoptosis: a review of programmed cell death," Toxicologic pathology, vol. 35, pp. 495-516, 2007.

[6] C. Tiloke, A. Phulukdaree, R. M. Gengan, and A. A. Chuturgoon, "Moringa oleifera aqueous leaf extract induces cell-cycle arrest and apoptosis in human liver hepatocellular carcinoma cells," Nutrition and cancer, vol. 71, pp. 1165-1174, 2019.

[7] B. A. Carneiro and W. S. El-Deiry, "Targeting apoptosis in cancer therapy," Nature reviews Clinical oncology, vol. 17, pp. 395-417, 2020.

[8] L. Pudziuvelyte, M. Stankevicius, A. Maruska, V. Petrikaite, O. Ragazinskiene, G. Draksiene et al., "Chemical composition and anticancer activity of Elsholtzia ciliata essential oils and extracts prepared by different methods," Industrial crops and products, vol. 107, pp. 90-96, 2017.

[9] F. Wang, X. Liu, Y. Chen, Y. An, W. Zhao, L. Wang et al., "Elsholtzia ciliata (Thunb.) Hyland: A Review of Phytochemistry and Pharmacology," Molecules, vol. 27, p. 6411, 2022.

[10] D. T. Nguyen, H. Tran, S. Schwaiger, H. Stuppner, and S. Marzocco, "Effect of Non‐Volatile Constituents of Elsholtzia ciliata (Thunb.) Hyl. from Southern Vietnam on Reactive Oxygen Species and Nitric Oxide Release in Macrophages," Chemistry & Biodiversity, vol. 18, p. e2000577, 2021.

[11] H.-H. Kim, J.-S. Yoo, H.-S. Lee, T. K. Kwon, T.-Y. Shin, and S.-H. Kim, "Elsholtzia ciliata inhibits mast cell-mediated allergic inflammation: role of calcium, p38 mitogen-activated protein kinase and nuclear factor-κ B," Experimental Biology and Medicine, vol. 236, pp. 1070-1077, 2011.

[12] D. J. Bhuyan, Q. V. Vuong, D. R. Bond, A. C. Chalmers, M. C. Bowyer, and C. J. Scarlett, "Eucalyptus microcorys leaf extract derived HPLC-fraction reduces the viability of MIA PaCa-2 cells by inducing apoptosis and arresting cell cycle," Biomedicine & Pharmacotherapy, vol. 105, pp. 449-460, 2018.

[13] H.-P. Huang, Y.-C. Chang, C.-H. Wu, C.-N. Hung, and C.-J. Wang, "Anthocyanin-rich Mulberry extract inhibit the gastric cancer cell growth in vitro and xenograft mice by inducing signals of p38/p53 and c-jun," Food Chemistry, vol. 129, pp. 1703-1709, 2011.

DOI: https://doi.org/10.34238/tnu-jst.6963

Refbacks

There are currently no refbacks.



Remember me